Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report

Hepatology Research

Volumn 37, Issue 7, 2007, Pages 517-523

  Torisu, Yuichi ^a   Ikeda, Kenji ^a   Kobayashi, Masahiro ^a   Hosaka, Tetsuya ^a   Sezaki, Hitomi ^a   Akuta, Norio ^a   Kawamura, Yusuke ^a   Yatsuji, Hiromi ^a   Suzuki, Fumitaka ^a   Suzuki, Yoshiyuki ^a   Arase, Yasuji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Alcohol; Diabetes mellitus; Hepatocellular carcinogenesis; Liver cirrhosis; Proportional hazard model

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; INSULIN; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ANAMNESIS; ARTICLE; CANCER RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 34249880490     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00077.x     Document Type: Article

References (40)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62: 163-82.
2. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-38.
3. The Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772-80.
4. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984; 87: 688-94.
5. Allison ME, Wreghitt T, Palmer CR, Alexander GJM. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
6. Mason AL, Lau JYN, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 329-33.
7. Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
8. Mehta SH, Brancati FL, Strathdee SA et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38: 50-6.
9. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
10. Buzzeri G, Chiarantini E, Cotrozzi G et al. Estimate of prevalence of glucose intolerance in chronic liver disease. Degree of agreement among some diagnostic criteria. Liver 1988; 8: 354-9.
11. Gentlie S, Luguercio C, Marmo R, Carbone L, Blanco CDV. Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract 1993; 22: 37-44.
12. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000; 92: 1096-9.
13. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low risk population, the non-Asian of Los Angels County, California. J Natl Cancer Inst 1991; 83: 1820-6.
14. Adami HO, Chow WH, Nyren O et al. Excess risk of primary liver cancer in patient with diabetes mellitus. J Nalt Cancer Inst 1996; 88: 1472-7.
15. Braga C, La Vecchia C, Negri E, Franceschi S. Attributable risks for hepatocellular carcinoma in Northern Italy. Eur J Cancer 1997; 83: 1820-6.
16. La Vecchia C, Negri E, Decali A, Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73: 204-7.
17. Hassan MM, Hwang LY, Hatten CJ et al. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-13.
18. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.
19. Lu SN, Lin TM, Chen CJ et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988; 62: 2051-5.
20. Kaplan EL, Meier P. Non-parametric estimation for incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
21. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrica 1982; 69: 553-66.
22. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 248-75.
23. SPSS Inc. SPSS for Windows Version 11.0 Manual. Chicago, USA: SPSS Inc., 2001.
24. Ikeda K, Saitoh S, Koida I et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis - a prospective observation of 795 cases with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
25. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Po S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
26. Takeuchi M, Fujimoto J, Niwamoto H, Yamamoto Y, Okamoto E. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig Dis Sci 1997; 42: 2264-9.
27. Sheu JC, Huang GT, Shih LN et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992; 103: 1322-7.
28. Paterlini P, Driss F, Pisi E, Franco D, Berthelot P, Brechot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: A study of a low-endemic area. Hepatology 1993; 17: 20-9.
29. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev 1992; 8: 229-57.
30. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-20.
31. Moore MA, Park CB, Tsuda H. Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev 1998; 7: 89-107.
32. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1990; 131: 254-62.
33. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415-21.
34. Silverman JF, O'Brien KF, Long S et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990; 85: 1349-55.
35. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189-212.
36. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999; 22: 1978-83.
37. Matteoni C, Younossi Z, Gramlich T, Bopari N, Liu Y, McCullough A. Non-alcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
38. Marchesini G, Brizi M, Morselli-Labate A et al. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-5.
39. Cotrim H, Parana R, Braga E, Lyra L. Non-alcoholic steatohepatitis and hepatocellular carcinoma: Natural history? Am J Gastroenterol 2000; 95: 3018-19.
40. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001; 51: 127-31.